Circulation
@circaha
RT/follows do not imply endorsement.
ID: 500370398
http://circ.ahajournals.org/ 23-02-2012 02:25:55
10,10K Tweet
76,76K Followers
3,3K Following
Intensive LDL-C lowering with Evolocumab may lead to greater relative reduction in cardiovascular events in patients with autoimmune or inflammatory diseases. André Zimerman @bweber04 ana laura kunzler @rgiuglaino ahajournals.org/doi/full/10.11…
